ClC-3 chloride channels are essential for cell proliferation and cell cycle progression in nasopharyngeal carcinoma

Bin Xu1, Jianwen Mao, Liwei Wang

  • 1Guangdong Pharmaceutical University, Guangzhou, China.

Insights

ClC-3 protein expression drives nasopharyngeal carcinoma cell proliferation and cell cycle progression. Inhibiting ClC-3 with antisense oligonucleotides reduced tumor cell growth and volume-activated chloride currents, suggesting ClC-3 as a potential cancer therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Physiology

Background:

  • ClC-3, a gene encoding a protein for volume-activated chloride channels, is implicated in tumor development.
  • Understanding ClC-3's role in cell proliferation is crucial for cancer research.

Purpose of the Study:

  • To investigate the mechanism by which ClC-3 affects cell proliferation in nasopharyngeal carcinoma CNE-2Z cells.
  • To determine if ClC-3 is a viable therapeutic target for human cancers.

Main Methods:

  • Utilized an antisense oligonucleotide "knock-down" strategy to inhibit ClC-3 expression.
  • Employed immunoblots and MTT assays to assess protein expression and cell proliferation.
  • Analyzed cell cycle progression, cloning efficiency, and volume-activated chloride currents (I(Cl,vol)) and regulatory volume decrease (RVD).

Main Results:

  • ClC-3 expression was cell cycle dependent and correlated with cell proliferation.
  • ClC-3 antisense oligonucleotide inhibited ClC-3 protein expression, cell proliferation, cloning efficiency, and induced S-phase arrest.
  • Inhibition of ClC-3 reduced I(Cl,vol) and RVD in a concentration-dependent manner, correlating positively with cell proliferation.

Conclusions:

  • ClC-3 plays a significant role in cell proliferation and cell cycle progression.
  • ClC-3 modulates I(Cl,vol) and RVD, impacting cancer cell growth.
  • ClC-3 represents a potential therapeutic target for human cancers, particularly nasopharyngeal carcinoma.

Related Concept Videos

Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...